The following discussion and analysis of the Company's financial condition and
results of operations should be read in conjunction with the financial
statements and the notes thereto contained elsewhere in this report. References
to the "Company," "us" or "we" refer to Armada Acquisition Corp. I.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form10-Q includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"). We have based these forward-looking statements on our current
expectations and projections about future events. These forward-looking
statements are subject to known and unknown risks, uncertainties and assumptions
about us that may cause our actual results, levels of activity, performance or
achievements to be materially different from any future results, levels of
activity, performance or achievements expressed or implied by such
forward-looking statements. In some cases, you can identify forward-looking
statements by terminology such as "may," "should," "could," "would," "expect,"
"plan," "anticipate," "believe," "estimate," "continue," or the negative of such
terms or other similar expressions. Factors that might cause or contribute to
such a discrepancy include, but are not limited to, those described in our other
Securities and Exchange Commission ("SEC") filings.
On February 2, 2023, we held an annual meeting of our stockholders (the "Annual
Meeting"). At the Annual Meeting, our stockholders approved an amendment to the
Company's Charter to extend the date by which the Company must consummate a
business combination or, if it fails to do so, cease its operations and redeem
or repurchase 100% of the shares of the Company's Common Stock issued in the
Company's initial public offering, from February 17, 2023 for up to six
additional months at the election of the Company, ultimately until as late as
August 17, 2023 (the "Extension"). We filed an amendment to the Company's
Charter with the Secretary of State of the State of Delaware reflecting the
Extension. In connection with the Extension, the holders of 11,491,148 shares of
Common Stock elected to redeem their shares at a per share redemption price of
approximately $10.19. As a result, we will remove approximately $117,079,879
from our Trust Account to pay such holders.
We are a blank check company incorporated in Delaware on November 5, 2020, for
the purpose of effecting a merger, stock exchange, asset acquisition, stock
purchase, reorganization or other similar business combination with one or more
businesses.
On August 17, 2021, we consummated our IPO of 15,000,000 units, at $10.00 per
unit, generating gross proceeds of $150 million.
Simultaneously with the closing of the IPO, we consummated the private placement
of 459,500 Private Shares for an aggregate purchase price of $4,595,000.
Upon the closing of the IPO on August 17, 2021, $150,000,000 ($10.00 per unit)
from the net proceeds of the sale of the units in the IPO and the sale of
Private Shares were placed in the Trust Account.
If we are unable to complete the initial Business Combination within the
Combination Period, we will (i) cease all operations except for the purpose of
winding up, (ii) as promptly as reasonably possible but not more than ten
business days thereafter, redeem 100% of the outstanding public shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account, including interest earned on the funds held in the Trust
Account and not previously released to us but net of taxes payable (and less up
to $100,000 of interest to pay dissolution expenses), divided by the number of
then outstanding public shares, which redemption will completely extinguish
public stockholders' rights as stockholders (including the right to receive
further liquidation distributions, if any), subject to applicable law, and
(iii) as promptly as reasonably possible following such redemption, subject to
the approval of our remaining stockholders and our board of directors, liquidate
and dissolve, subject (in the case of (ii) and (iii) above) to our obligations
under Delaware law to provide for claims of creditors and the requirements of
other applicable law.
On February 2, 2023, we held an annual meeting of our stockholders (the "Annual
Meeting"). At the Annual Meeting, our stockholders approved an amendment to the
Company's Charter to extend the date by which the Company must consummate a
business combination or, if it fails to do so, cease its operations and redeem
or repurchase 100% of the shares of the Company's Common Stock issued in the
Company's initial public offering, from February 17, 2023 for up to six
additional months at the election of the Company, ultimately until as late as
August 17, 2023 (the "Extension"). We filed an amendment to the Company's
Charter with the Secretary of State of the State of Delaware reflecting the
Extension. In connection with the Extension, the holders of 11,491,148 shares of
Common Stock elected to redeem their shares at a per share redemption price of
approximately $10.17 per Feb 2, 2023 filed Form 8-K. As a result, we will remove
approximately $116,864,975 per Feb 2, 2023 filed Form 8-K from our Trust Account
to pay such holders.
18
--------------------------------------------------------------------------------
Table of Contents
Business Combination Agreement
On December 17, 2021, we announced that we entered into a business combination
agreement, dated as of December 17, 2021, with Rezolve Limited, a private
limited liability company registered under the laws of England and Wales
("Rezolve"), Rezolve Group Limited, a Cayman Islands exempted company ("Cayman
NewCo"), and Rezolve Merger Sub, Inc., a Delaware corporation ("Rezolve Merger
Sub") (such business combination agreement, the "Business Combination
Agreement," and such business combination, the "Business Combination").
Pursuant to the terms of the Business Combination Agreement, we, Cayman NewCo,
Rezolve and Rezolve Merger Sub will effect a series of transactions including,
among other things:
• a company reorganization pursuant to which Cayman NewCo will enter into a
transfer and exchange agreement (the "Transfer and Exchange Agreement"),
pursuant to which, each Key Company Shareholder (as defined in the
Business Combination Agreement) will transfer to Cayman NewCo his, her or
its respective shares of Rezolve in exchange for ordinary shares in
Cayman NewCo, such that following the effectiveness of such transfers,
the Key Company Shareholders will own the same proportionate equity
interests of Cayman NewCo that such Key Company Shareholders owned
immediately before such transfers (with the balance of the other shares
of Rezolve to be transferred to Cayman NewCo in exchange for an
equivalent number and class of shares in Cayman NewCo) and, immediately
thereafter, each Key Company Shareholder will transfer to Cayman NewCo
all of his, her or its respective shares of Cayman NewCo so received in
exchange for his, her or its applicable pro rata portion of the aggregate
stock consideration in accordance with the terms and conditions set forth
in the Business Combination Agreement and in such Transfer and Exchange
Agreement (with all other shareholders of Rezolve to transfer to Cayman
NewCo all of his, her or its respective shares of Cayman NewCo received
in exchange for his, her or its applicable pro rata portion of the
aggregate stock consideration); and
• following the Company Reorganization, but in no event earlier than ten
(10) days following the effectiveness of each of the transactions
contemplated by the Company Reorganization: (a) Rezolve Merger Sub shall
be merged with and into Armada whereupon Rezolve Merger Sub will cease to
exist and with Armada surviving the Merger as a subsidiary of Cayman
NewCo; and (b) Armada shall loan all of its remaining cash in the Trust
Account to Cayman NewCo in exchange for a promissory note, to enable
Cayman NewCo to fund working capital and transaction expenses. Pursuant
to the Merger, all of the outstanding securities of Armada will be
converted into the right to receive an equivalent number of securities of
Cayman NewCo of the same type and with the same terms.
As a result of the Business Combination (i) the shareholders of Rezolve will
receive a number of Cayman NewCo ordinary shares equal to (A) the quotient
obtained by dividing (x) $1,750,000,000 by (y) $10.00 minus (B) the Outstanding
Warrant Number (as defined in the Business Combination Agreement) and minus
(C) the Acquisition Shares (as defined in the Business Combination Agreement)
(to the extent such Acquisition Shares are not already issued on or prior to the
Company Reorganization Date), and (ii) the combined company will pay or cause to
be paid all of the transaction expenses.
The consummation of the Business Combination is subject to the satisfaction or
waiver of certain customary closing conditions of the respective parties,
including the completion of the Company Reorganization, the requisite approvals
of our stockholders and Rezolve's shareholders and regulatory approvals.
In connection with the execution of the Business Combination Agreement, we and
Cayman NewCo entered into certain subscription agreements, each dated
December 17, 2021 (the "Subscription Agreements"), with certain investors,
pursuant to which such investors have agreed to purchase an aggregate of
2,050,000 Ordinary Shares (the "PIPE Shares") of Cayman NewCo (together, the
"Subscriptions"), for a purchase price of $10.00 per share, for an aggregate
purchase price of $20.5 million to be issued substantially concurrently with the
consummation of the Business Combination. The obligations of each party to
consummate the Subscriptions are conditioned upon, among other things, customary
closing conditions.
19
--------------------------------------------------------------------------------
Table of Contents
On November 10, 2022 (the "Amendment Date"), Armada and Rezolve entered into a
First Amendment to the Business Combination Agreement (the "Amendment"). Except
as specifically set forth in the Amendment, all other terms and provisions of
the original Business Combination Agreement remain unaffected and continue in
full force and effect. Below is a summary of the key amendments:
Structure of the Business Combination
The Amendment amends the Business Combination Agreement so that Rezolve is
substituted for Cayman Newco as applicable. As a result of this amendment,
Cayman Newco is no longer a party to the Business Combination Agreement or the
Business Combination, and Rezolve will be the listed entity upon the closing. As
necessary, Armada and Rezolve have agreed to make any amendments to the
Ancillary Documents as are necessary or appropriate to effect the substitution
of Rezolve for Cayman Newco in the Business Combination.
Termination
The original Business Combination Agreement allowed the parties to terminate
such agreement if certain conditions described therein are satisfied. One such
condition allowed either Armada or Rezolve to terminate the Business Combination
Agreement if the Business Combination is not consummated by August 31, 2022 (the
"Termination Date"). The Amendment extended the Termination Date to the later of
(i) January 31, 2023 or (ii) fifteen (15) days prior to the last date on which
Armada may consummate a Business Combination, as defined in and pursuant to the
Second Amended and Restated Certificate of Incorporation of Armada, as approved
or extended by the stockholders of Armada from time to time.
The original Business Combination Agreement allowed either Armada or Rezolve to
terminate the Business Combination Agreement in the event the aggregate
transaction proceeds provided or committed to be provided are not more than
fifty million dollars ($50,000,000). The Amendment deleted this provision in its
entirety.
Incentive Plan
Under the Amendment, Armada and Rezolve agreed and acknowledged that following
June 30, 2023, the Board has the right to increase the number of Rezolve shares
under the Rezolve Incentive Plan by up to 5% per annum for each calendar year
commencing in and including 2023, subject to appropriate shareholder approval as
required by applicable law or the NASDAQ rules and regulations.
Articles of Association
Pursuant to the Amendment, Armada and Rezolve agreed upon the form of the
articles of association of Rezolve to be adopted and become effective upon
closing of the Business Combination.
We cannot assure you that our plans to complete our initial business combination
will be successful.
Results of Operations
For the three months ended December 31, 2022, we had a net income of $607,027,
which consisted of trust interest income of $1,289,673, offset by formation and
operating costs of $394,352, stock-based compensation of $27,963, and income tax
provision of $260,331.
For the three months ended December 31, 2021, we had a net loss of $2,036,114,
which consisted of operating costs and costs related to a prospective initial
Business Combination of $2,010,995 and stock-based compensation of $27,963,
partially offset by trust interest income of $2,844.
Following the exercise of the automatic extension of the deadline for us to
complete an initial business combination under our second amended and restated
certificate of incorporation ("Charter"), we had until February 17, 2023 (or 18
months following our initial public offering) to consummate a business
combination (unless we further extend the period of time to consummate a
business
20
--------------------------------------------------------------------------------
Table of Contents
combination) (the "Combination Period"). At our Annual Meeting held on February
2, 2023, our stockholders approved an amendment to our Charter to consummate a
business combination (unless we further extend the period of time to consummate
a business combination) (the "Combination Period"). However, if we are unable to
complete the initial Business Combination within the Combination Period (unless
such period is further extended pursuant to the approval of our stockholders),
we will (i) cease all operations except for the purpose of winding up, (ii) as
promptly as reasonably possible but not more than ten business days thereafter,
redeem 100% of the outstanding public shares, at a per-share price, payable in
cash, equal to the aggregate amount then on deposit in the Trust Account,
including interest earned on the funds held in the Trust Account and not
previously released to the Company but net of taxes payable (and less up to
$100,000 of interest to pay dissolution expenses), divided by the number of then
outstanding public shares, which redemption will completely extinguish public
stockholders' rights as stockholders (including the right to receive further
liquidation distributions, if any), subject to applicable law, and (iii) as
promptly as reasonably possible following such redemption, subject to the
approval of our remaining stockholders and the Company's board of directors,
liquidate and dissolve, subject (in the case of (ii) and (iii) above) to our
obligations under Delaware law to provide for claims of creditors and the
requirements of other applicable law. As of December 31, 2022 the Trust Account
has released $182,069 to the Company to pay tax obligations.
We have also agreed to reimburse the Sponsor for office space, secretarial and
administrative services provided to members of our management team, in an amount
not to exceed $10,000 per month. Upon completion of our initial business
combination or our liquidation, we will cease paying these monthly fees. For the
three months ended December 31, 2022 and 2021, the Company paid $30,000 under
this agreement
Liquidity and Going Concern
As of December 31, 2022, we had cash outside our Trust Account of $363,247,
available for working capital needs. All remaining cash was held in the Trust
Account and is generally unavailable for our use, prior to an initial business
combination.
On August 17, 2021, we completed the sale of 15,000,000 Units at $10.00 per
Unit, generating gross proceeds of $150,000,000.
Simultaneously with the consummation of the IPO, the Company consummated the
private placement of 459,500 shares of common stock ("Private Shares"), at a
price of $10.00 per share for an aggregate purchase price of $4,595,000.
In connection with the IPO, the underwriters were granted a 45-day option from
the date of the prospectus for the IPO to purchase up to 2,250,000 additional
units to cover over-allotments, if any. On October 1, 2021 this option expired
unused.
Following our IPO and the sale of the Private Shares, a total of $150,000,000
($10.00 per Unit) was placed in the Trust Account. We incurred $3,537,515 in IPO
related costs, including $1,500,000 of underwriting fees and $2,037,515 of other
costs.
On May 9, 2022, the Sponsor loaned us the aggregate amount of $483,034 in order
to assist us to fund our working capital needs. On November 10, 2022 our Sponsor
loaned us $1,500,000 in order to cover the additional contribution to the trust
account required in connection with the automatic extension of our deadline to
complete our Initial Business Combination and $450,000 for our working capital
needs. These loans are evidenced by four promissory notes in the aggregate
principal amount of $2,433,034 from us, as maker, to our Sponsor, as payee. The
promissory notes are non-interest bearing and due on the earlier of: (i) the
liquidation or release of all of the monies held in the Trust Account or
(ii) the date on which we consummate an acquisition, merger or other business
combination transaction involving us or our affiliates. The principal balance
may be prepaid at any time. During July 2022, we fully repaid one of the
promissory notes in the amount of $187,034 which represented monies loaned to us
for the payment of Delaware franchise taxes. We utilized the interest earned on
the Trust Account to repay the promissory note, $120,000 of which was
distributed to it from the Trust Account during June 2022, and $62,069 of which
was distributed to it from the Trust Account during July 2022. We also paid
$44,246 on behalf of the Sponsor for tax services in August and September
2022.The aggregate balance outstanding under all promissory notes was $2,201,754
and $251,754 of December 31, 2022 and September 30, 2022, respectively.
As of December 31, 2022, we had investment held in the Trust Account of
$153,634,598. The investment held in the Trust Account was held in U.S. Treasury
Bills with a maturity of 185 days or less and in money market funds which invest
in U.S. Treasury securities. Interest income on the balance in the Trust Account
may be used by us to pay taxes.
21
--------------------------------------------------------------------------------
Table of Contents
As of December 31, 2022, the Trust Account has released $182,069 to the Company
to pay franchise tax obligations. In connection with the Extension approved by
our stockholders on February 2, 2023, the holders of 11,491,148 shares of Common
Stock elected to redeem their shares at a per share redemption price of
approximately $10.17. As a result, approximately $116,864,975 will be removed
from the Company's Trust Account to pay such holders. For the three months ended
December 31, 2022, cash used in operating activities was $264,331. Net income of
$607,027 was impacted primarily by trust interest income of $1,289,673, changes
in operating assets and liabilities of $390,352 and stock-based compensation of
$27,963.
For the three months ended December 31, 2021, cash used in operating activities
was $237,890. Net loss of $2,036,114 was impacted primarily by changes in
operating assets and liabilities of $1,773,105, stock-based compensation of
$27,963, and trust interest income of $2,844.
We intend to use substantially all of the funds held in the Trust Account,
including any amounts representing interest earned on the Trust Account to
complete our initial business combination. We may withdraw interest to pay our
taxes and liquidation expenses if we are unsuccessful in completing a business
combination. We estimate our annual franchise tax obligations to be $200,000,
which is the maximum amount of annual franchise taxes payable by us as a
Delaware corporation per annum, which we may pay from funds from the Public
Offering held outside of the Trust Account or from interest earned on the funds
held in the Trust Account and released to us for this purpose. Our 2021 Delaware
franchise tax amounted to $182,069. Our annual income tax obligations will
depend on the amount of interest and other income earned on the amounts held in
the Trust Account reduced by our operating expense and franchise taxes. We
expect the interest earned on the amount in the Trust Account will be sufficient
to pay our income taxes. To the extent that our equity or debt is used, in whole
or in part, as consideration to complete our initial business combination, the
remaining proceeds held in the Trust Account will be used as working capital to
finance the operations of the target business or businesses, make other
acquisitions and pursue our growth strategies. As of December 31, 2022 the Trust
Account has released $182,069 to the Company to pay tax obligations.
Further, our sponsor, officers and directors or their respective affiliates may,
but are not obligated to, loan us funds as may be required. If we complete a
business combination, we would repay the loans. In the event that a business
combination does not close, we may use a portion of proceeds held outside the
Trust Account to repay the loans, but no proceeds held in the Trust Account
would be used to repay the loans. Such loans would be evidenced by promissory
notes and would be repaid upon consummation of a business combination, without
interest. As of December 31, 2022, there was a balance due to the Sponsor of
$2,201,754 under the loans.
On November 10, 2022, our Sponsor loaned us $1.5 million in order to cover the
additional contribution to the trust account required in connection with the
automatic extension of the deadline to complete our initial business combination
and $0.45 million dollars for working capital purposes. However, if our
estimates of the operating costs are less than the actual amount necessary to do
so, we may have insufficient funds available to operate our business prior to
our business combination. Under the original Business Combination Agreement,
either we or Rezolve could have terminated the Business Combination Agreement if
the aggregate transaction proceeds (excluding certain amounts invested by the
investors specified in the Business Combination Agreement) provided or committed
to be provided was not more than $50 million. The Amendment entered into in
November 2022 eliminated this provision in its entirety. If we are unable to
complete a business combination (including the Business Combination) because we
do not have sufficient funds available to us, we will be forced to cease
operations and liquidate the Trust Account.
In connection with our assessment of going concern considerations in accordance
with FASB Accounting Standards Update ("ASU") 2014-15, "Disclosures of
Uncertainties about an Entity's Ability to Continue as a Going Concern," our
management has determined that we have and will continue to incur significant
costs in pursuit of acquisition plans which, in addition to possibility that we
might not be able to a close business combination and be forced to liquidate
after August 17, 2023 raises substantial doubt about our ability to continue as
a going concern. No adjustments have been made to the carrying amounts of assets
or liabilities that might be necessary if we are unable to continue as a going
concern.
22
--------------------------------------------------------------------------------
Table of Contents
Critical Accounting Policies
The preparation of these unaudited condensed financial statements in conformity
with US GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the unaudited condensed financial
statements and the reported amounts of expenses during the reporting period.
Actual results could differ from those estimates. We have identified the
following as our critical accounting policies:
Common Stock Subject to Possible Redemption
The Company accounts for its common stock subject to possible redemption in
accordance with the guidance in ASC Topic 480 "Distinguishing Liabilities from
Equity." Common stock subject to mandatory redemption (if any) are classified as
a liability instrument and measured at fair value. Conditionally redeemable
common stock (including common stock that feature redemption rights that are
either within the control of the holder or subject to redemption upon the
occurrence of uncertain events not solely within the Company's control) are
classified as temporary equity. At all other times, common stock are classified
as stockholders' equity. The Company's shares of common stock feature certain
redemption rights that are considered to be outside of the Company's control and
subject to the occurrence of uncertain future events. Accordingly, 15,000,000
shares of common stock subject to possible redemption are presented at
redemption value as temporary equity, outside of the stockholders' equity
section of the Company's condensed balance sheets.
The Company recognizes changes in redemption value immediately as they occur.
Immediately upon the closing of the IPO, the Company recognized the
remeasurement adjustment from initial carrying amount to redemption book value.
The change in the carrying value of redeemable common stock resulted in charges
against additional paid-in capital.
Net Income (Loss) Per Common Stock
The Company complies with accounting and disclosure requirements of FASB ASC
Topic 260, "Earnings Per Share". Net income (loss) per common stock is computed
by dividing net loss by the weighted average number of common stock outstanding
for the period. Remeasurement adjustments associated with the redeemable shares
of common stock is excluded from earnings per share as the redemption value
approximates fair value.
The calculation of diluted income (loss) per share does not consider the effect
of the warrants issued in connection with the IPO because the warrants are
contingently exercisable, and the contingencies have not yet been met. The
warrants are exercisable to purchase 7,500,000 shares of common stock in the
aggregate. As of December 31, 2022 and 2021, the Company did not have any
dilutive securities or other contracts that could, potentially, be exercised or
converted into common stock and then share in the earnings of the Company. As a
result, diluted net income (loss) per common stock is the same as basic net
income (loss) per common stock for the periods presented.
Accretion of the carrying value of common stock subject to redemption value is
excluded from net income (loss) per common stock because the redemption value
approximates fair value.
Recent Accounting Standards
Management does not believe that any recently issued, but not effective,
accounting standards, if currently adopted, would have a material effect on the
Company's financial statements.
Off-Balance Sheet Arrangements; Commitments and Contractual Obligations
We have no obligations, assets or liabilities which would be considered
off-balance sheet arrangements. We do not participate in transactions that
create relationships with unconsolidated entities or financial partnerships,
often referred to as variable interest entities, which would have been
established for the purpose of facilitating off-balance sheet arrangements.
We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of
other entities, or entered into any non-financial agreements involving assets.
23
--------------------------------------------------------------------------------
Table of Contents
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease
obligations or long-term liabilities other than an administrative agreement to
reimburse our sponsor for office space, secretarial and administrative services
not to exceed $10,000 per month from the date of closing of the Public Offering.
Upon completion of a business combination or the Company's liquidation, the
Company will cease paying these monthly fees.
Financial Advisory Fee
We engaged Cohen & Company Capital Markets, a division of J.V.B. Financial
Group, LLC ("CCM"), an affiliate of a member of the Sponsor, to provide
consulting and advisory services in connection with the IPO, for which it
received an advisory fee equal to one (1.0) percent of the aggregate proceeds of
the IPO, or $1,500,000, upon closing of the IPO. Affiliates of CCM have and
manage investment vehicles with a passive investment in the Sponsor. On
August 18, 2021, we paid to CCM an aggregate of $1,500,000. CCM has agreed to
defer the payment of the portion of the advisory fee attributable to
over-allotment option until the consummation of the initial Business
Combination. CCM is engaged to represent our interests only. We have also
engaged CCM as an advisor in connection with the initial Business Combination
for which it will earn an advisory fee of 2.25% of the gross proceeds of the
IPO, or $3,375,000, payable at closing of the Business Combination. On
October 1, 2021 the underwriters' over-allotment option expired unused resulting
in no additional fees and commissions related to the over-allotment option to be
not payable to CCM by the Company.
Business Combination Marketing Agreement
We engaged the representative of the underwriter as an advisor in connection
with Business Combination to assist in holding meetings with our stockholders to
discuss the potential Business Combination and the target business' attributes,
introduce us to potential investors that are interested in purchasing our
securities in connection with the initial Business Combination and assist us
with press releases and public filings in connection with the Business
Combination. We will pay the representative a cash fee for such services upon
the consummation of the initial Business Combination in an amount equal to 2.25%
of the gross proceeds of the IPO, or $3,375,000. We will also pay the
representative a separate capital market advisory fee of $2,500,000 upon
completion of the initial Business Combination. Additionally, we will pay the
representative a cash fee equal to 1.0% of the total consideration payable in
the proposed Business Combination if the representative introduces us to the
target business with which the Company completes a Business Combination.
Right of First Refusal
If we determine to pursue any equity, equity-linked, debt or mezzanine financing
relating to or in connection with an initial Business Combination, then
Northland Securities, Inc. shall have the right, but not the obligation, to act
as book running manager, placement agent and/or arranger, as the case may be, in
any and all such financing or financings.
This right of first refusal extends from the date of the IPO until the earlier
of the consummation of an initial Business Combination or the liquidation of the
Trust Account if the Company fails to consummate a Business Combination during
the required time period.
Registration Rights
The holders of the Founder Shares issued and outstanding on the date of the IPO,
as well as the holders of the representative shares, Private Shares and any
shares the sponsor, officers, directors or their affiliates may issue in payment
of Working Capital Loans made to us, will be entitled to registration rights
pursuant to an agreement to be signed prior to or on the effective date of the
IPO. The holders of a majority of these securities (other than the holders of
the representative shares) are entitled to make up to two demands that we
register such securities. The holders of the majority of the Founder Shares can
elect to exercise these registration rights at any time commencing three months
prior to the date on which these shares of common stock are to be released from
escrow. The holders of a majority of the Private Shares and shares issued to the
Sponsor, officers, directors or their affiliates in payment
24
--------------------------------------------------------------------------------
Table of Contents
of Working Capital Loans made to us can elect to exercise these registration
rights at any time after we consummate a business combination. In addition, the
holders have certain "piggy-back" registration rights with respect to
registration statements filed subsequent to the consummation of a business
combination. We will bear the expenses incurred in connection with the filing of
any such registration statements.
Underwriting Agreement
The underwriters were paid a cash underwriting discount of 1.0% of the gross
proceeds of the IPO, or $1,500,000 (and are entitled to an additional
$225,000 of deferred underwriting commission payable at the time of an initial
Business Combination if the underwriters' over-allotment is exercised in full).
On October 1, 2021 the underwriters' over-allotment option expired unused
resulting in the $225,000 deferred underwriting commission to be not payable to
the underwriter.
Business Combination Agreement
We are party to the Business Combination Agreement with Rezolve, Cayman NewCo
and Rezolve Merger Sub, dated December 17, 2021. Completion of the proposed
transaction pursuant to the Business Combination Agreement is subject to
customary closing conditions, including the approval of the Company's and
Rezolve's respective stockholders and regulatory approvals.
In connection with the execution of the Business Combination Agreement, certain
investors have agreed to purchase an aggregate of 2,050,000 ordinary shares of
Cayman NewCo for the purchase price of $10.00 per share, for an aggregate
purchase price of $20.5 million pursuant to certain subscription agreements (the
"Subscription Agreements"). The obligations of each party under the subscription
agreements are conditioned upon customary closing conditions and the
consummation of the Business Combination.
On November 10, 2022, Armada and Rezolve entered into a First Amendment to the
Business Combination Agreement (the "Amendment"), to among other things, extend
the date on which either party to the Business Combination Agreement had the
right to terminate the Business Combination Agreement if the Business
Combination had not been completed by such date, and change the structure of the
Business Combination such that Cayman NewCo is no longer a party to the Business
Combination Agreement or the Business Combination.
Concurrently with the execution and delivery of the Business Combination
Agreement, the Company and the Key Company Shareholders (as defined in the
Business Combination Agreement) have entered into the Transaction Support
Agreement (the "Transaction Support Agreement"), pursuant to which, among other
things, the Key Company Shareholders have agreed to (a) vote in favor of the
Company Reorganization (b) vote in favor of the Business Combination Agreement
and the agreements contemplated thereby and the transactions contemplated
thereby, (c) enter into the Investor Rights Agreement (as described below) at
Closing and (d) the termination of certain agreements effective as of Closing.
© Edgar Online, source Glimpses